title: Vanishing glioblastoma after corticosteroid therapy: does this occurrence modify our surgical strategy?
authors: Department of Neurological Sciences-Neurosurgery, University of Rome Sapienza, Italy. deliaale@gmail.com
authors: Alessandro
authors: A
authors: D'Elia
authors: Vincenza
authors: V
authors: Maiola
authors: Biagia
authors: B
authors: La Pira
authors: Elena
authors: E
authors: Arcovio
authors: Christian
authors: C
authors: Brogna
authors: Alessandro
authors: A
authors: Frati
authors: Francesca
authors: F
authors: Santoro
authors: Antonio
authors: A
authors: Santoro
authors: Maurizio
authors: M
authors: Salvati
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D059186:Chemoradiotherapy, Adjuvant; D003337:Corpus Callosum / Q000473:pathology; D003907:Dexamethasone / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D038361:Neuronavigation / Q000379:methods; D019635:Neurosurgical Procedures; D010296:Parietal Lobe / Q000473:pathology; D010347:Patient Care Planning
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D003907:Dexamethasone